A new publication involving BPC-157 was released on September 19, 2026. Titled "BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence," it appears in the International Journal of Molecular Sciences.
The publication is described as a critical review of existing preclinical evidence related to BPC-157 in rodent models of ischemia-reperfusion injury. No specific findings, outcomes, or conclusions from the review have been provided beyond its title and publication details.
BPC-157 remains classified as an unapproved research compound. This publication does not represent a regulatory action, trial result, or safety notice. It is listed here as a record of new academic literature entering the field.
Readers interested in more background on this compound can consult the compound overview for additional context.